The US Is Paying Way Too Much for Remdesivir
by Rohan Chalasani, Walid Gellad from on (#55TXC)
The inflated price of the anti-Covid drug may not bother hospitals, insurance companies, or even patients. But it's still not justified.
External Content
| Source | RSS or Atom Feed |
| Feed Location | http://feeds.wired.com/wired/index |
| Feed Title | |
| Feed Link | http://feeds.wired.com/ |
| Reply | 0 comments |